STRS Ohio’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

STRS Ohio’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,100	Closed	-$910K	–	2139
2022 Q2	$910K	Buy	12,100 +700	+6%	+$31.1K	﹤0.01%	971
2022 Q1	$306K	Hold	11,400	–	–	﹤0.01%	1594
2021 Q4	$543K	Hold	11,400	–	–	﹤0.01%	1449
2021 Q3	$757K	Sell	11,400 -1,200	-10%	-$85.5K	﹤0.01%	1309
2021 Q2	$983K	Hold	12,600	–	–	﹤0.01%	1178
2021 Q1	$1.19M	Hold	12,600	–	–	﹤0.01%	1040
2020 Q4	$1.53M	Buy	12,600 +400	+3%	+$43.8K	0.01%	811
2020 Q3	$1.06M	Sell	12,200 -1,600	-12%	-$111K	﹤0.01%	898
2020 Q2	$891K	Sell	13,800 -3,500	-20%	-$202K	﹤0.01%	953
2020 Q1	$772K	Buy	17,300 +15,500	+861%	+$823K	﹤0.01%	836
2019 Q4	$112K	Hold	1,800	–	–	﹤0.01%	1762
2019 Q3	$67K	Hold	1,800	–	–	﹤0.01%	1824
2019 Q2	$73K	Buy	+1,800	New	+$64.2K	﹤0.01%	1868

STRS Ohio's TPTX Position: Q3 2022 in Review

STRS Ohio sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 12,100 shares — an estimated $910K sold.

STRS Ohio first reported a position in TPTX in Q2 2019 and held it in 13 quarters. The position peaked at $1.53M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

STRS Ohio reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
STRS Ohio sold 12,100 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $910K.
STRS Ohio first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
STRS Ohio's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.53M in Q4 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on STRS Ohio's 13F filing for Q3 2022, filed 27 Oct 2022.